May 3, 2013

Rates of testicular cancer among young men have risen significantly over the last two decades across racial and ethnic groups, according to a new study, and researchers are wondering what accounts for it.

May 2, 2013

Drug makers Boehringer Ingelheim and Eli Lilly have started a campaign designed to educate healthcare professionals about the role a type of protein plays in maintaining blood-sugar balance.

May 2, 2013

The Justice Department reported it will appeal a recent judicial decision that would require removing any age restriction from the purchase of the Plan B emergency contraceptive, according to a report published in USA Today.

May 2, 2013

The vast majority of mothers experience pain throughout their bodies, according to a new survey.

May 2, 2013

A company that manages pharmacy services for employer groups and health plans has selected a company founded by the National Community Pharmacists Association for its medication therapy management services.

May 1, 2013

Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.

May 1, 2013

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

May 1, 2013

South University has appointed a new dean of its pharmacy school, the university announced.

May 1, 2013

PharmaSmart International's blood-pressure screening program is in use in all the stores of a regional retail pharmacy chain in the Northeast.

May 1, 2013

Prasco Labs has signed a deal with WellSpring Pharmaceutical Corp. to market an authorized generic version of a drug for a rare tumor disorder.

May 1, 2013

A search feature that allows pharmacies to quickly determine why patients are calling so they can better serve their needs and a patient registration system that allows easier enrollment in medication-time reminders, disease management and smoking-cessation programs are among the new features of the latest version of PrescribeWellness' software system.

May 1, 2013

Rite Aid has signed on as a platinum sponsor of the Entertainment Industry Foundation Revlon Run/Walk for Women, the retail pharmacy chain said Wednesday.

May 1, 2013

Teva Pharmaceutical Industries has launched a generic inhaler used to treat bronchospasm, the company said.

April 30, 2013

The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.

April 30, 2013

The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.

April 30, 2013

The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

April 30, 2013

The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.

April 30, 2013

The Food and Drug Administration declined to approve two drugs for HIV made by Gilead Sciences for which the company was seeking approval for use as part of treatment regimens.

April 29, 2013

Healthcare technology company CDW Healthcare and ConnectedLiving, an organization that provides technology for the elderly, have a deal to get senior living communities online, the two companies said.

April 29, 2013

An organization focused on a fatal genetic disorder that affects men has launched a mobile app that allows for the location of clinical trials and clinics.

April 29, 2013

Electronic health platform Fitango is creating a three-part action plan to support childhood immunizations, the company said.

April 29, 2013

A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.

April 29, 2013

The risk of Lyme disease in dogs will be "extremely high" this year, an expert group has warned.

April 26, 2013

Generic drug maker Actavis is settling a patent-infringement suit with Purdue Pharma concerning the opioid painkiller OxyContin, Actavis said, saying it expected to make more than $100 million in the deal between 2014 and 2015.